| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Net Power names Lee Shuman as chief financial officer | ||
| Mo | CMC appoints Michael Dumais to board of directors | ||
| Mo | Copa Holdings reports 14.8% capacity increase in March | ||
| Mo | Jack in the Box appoints Eduardo Luz to board, two directors retire | ||
| Mo | Credo to acquire DustPhotonics for $750M to expand optical tech | ||
| Mo | Navitas Semiconductor adds ex-Broadcom executive to board | ||
| Mo | Sana Biotechnology partners with Mayo Clinic on diabetes therapy | ||
| Mo | FedEx CFO John Dietrich to step down following freight spinoff | ||
| Mo | Allogene Therapeutics plans $175 million stock offering | ||
| Mo | Red White & Bloom subsidiary wins Ayurcann asset bid | ||
| Mo | Revolution Medicines plans $1 billion dual offering | ||
| Mo | Gevo appoints Joan Cetera as VP of communications | ||
| Mo | William Blair reiterates Ocular Therapeutix stock rating on trial data | ||
| Mo | Mizuho raises Spyre stock price target to $84 on trial data | ||
| Mo | Mizuho raises Ideaya Biosciences stock price target on trial data | ||
| Mo | Freedom Broker cuts Beam Global stock price target on cash concerns | ||
| Mo | Mizuho cuts CommVault stock price target on valuation concerns | ||
| Mo | Oppenheimer raises Ideaya Biosciences price target on trial data | ||
| Mo | Freedom Broker raises Aehr Test Systems stock price target to $61 on strong bookings | ||
| Mo | Leerink reiterates Eli Lilly stock rating on positive trial data | ||
| Mo | Syre Therapeutics stock price target raised to $106 by Leerink | ||
| Mo | Arrow Electronics, Avnet rallied 9% as analyst upgrades on improving sentiment | ||
| Mo | Evercore ISI reiterates Netflix stock rating ahead of earnings | ||
| Mo | Truist raises Ideaya Biosciences stock price target on trial data | ||
| Mo | Warner Music Group invests in Latin music distributor TuStreams |